focus -WSS

focus

author：explore 2025-09-06 01:55:43 - browse：38846

Jamy Ard (left) and Robert Lustig (right) on the 2023 STAT Breakthrough Summit stage -- coverage from STAT — Obesity experts Jamy Ard (left) and Robert Lustig speak at a panel during the 2023 STAT Breakthrough Summit. Sarah Gonzalez for STAT

Amid rising demand for drugs like Wegovy, Ozempic, and Mounjaro that can lead to significant weight loss, some obesity experts are concerned about the drugs’ costs — both to patients’ finances and to their health.

Speaking at a panel on new obesity treatments at the STAT Breakthrough Summit in San Francisco on Thursday, one expert cited a large clinical trial for Wegovy that showed that about 40% of the weight participants lost was lean mass. Side effects like nausea, vomiting, and a possible link to rare cases of pancreatitis also still plague this newest class of drugs, which imitate the effects of a hormone called glucagon-like peptide 1 (GLP) that helps people feel full.

“That’s what starvation does. You lose equal amounts of muscle and fat,” said Robert Lustig, emeritus professor of pediatrics at the University of California, San Francisco. “If you’re a person 60 years old or over and you’re losing muscle, your risk of dying just went up exponentially. So we may be … robbing Peter to pay Paul.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： White House touts steps to stem shortages of cancer treatments

WSS

Pig kidney works a record two months in donated body

IRA could hurt research into orphan drugs for rare diseases

New weight loss drugs vying to be the next Wegovy or Mounjaro

FDA proposes changes to key medical devices approval pathway

Does good food count as health care? Study aims to find out

Congress must reauthorize a committee to support older Americans

entertainment

focus

entertainment

Continuity nursing helped my family in our darkest PICU moments

Weight loss drug costs may need more research, senator suggests

What does generative AI mean for health care? We asked experts

Hospitals consider fixing cancer drug shortages on their own

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Hospitals look to new technology to keep health care workers safe

As demand for Covid shots wanes, Moderna seeks its next success

David Sabatini, ex

Jerome Adams on the need for new antivirals for Covid

Food makers tried to stack nutrition panel with preferred experts

focus

Does good food count as health care? Study aims to find out

New Covid vaccine is recommended for everyone 6 months or older

Regeneron agrees to White House price limits on anti

In key trial, Verve's treatment lowers cholesterol levels in patients

A daunting task: navigating dual Medicare, Medicaid eligibility

PEPFAR is under serious threat — and so is global health

focus

knowledge

entertainment

focus